| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
10,915 |
9,408 |
$1.55M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
8,065 |
6,554 |
$1.29M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
1,234 |
985 |
$161K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
2,148 |
1,794 |
$153K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
2,489 |
1,866 |
$148K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
2,080 |
1,341 |
$73K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
725 |
612 |
$69K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
388 |
345 |
$62K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
774 |
677 |
$59K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
768 |
619 |
$56K |
| 71045 |
Radiologic examination, chest; single view |
351 |
290 |
$49K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
2,371 |
591 |
$48K |
| 80053 |
Comprehensive metabolic panel |
6,608 |
5,205 |
$44K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
8,156 |
6,359 |
$40K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
1,193 |
877 |
$40K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
633 |
222 |
$38K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
735 |
620 |
$29K |
| 71046 |
Radiologic examination, chest; 2 views |
334 |
271 |
$29K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
290 |
265 |
$27K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
1,106 |
867 |
$25K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
384 |
203 |
$19K |
| 36415 |
Collection of venous blood by venipuncture |
7,375 |
5,911 |
$19K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
259 |
170 |
$18K |
| 92526 |
|
220 |
87 |
$16K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
41 |
19 |
$15K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
694 |
189 |
$13K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
191 |
138 |
$13K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
309 |
283 |
$8K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
321 |
258 |
$8K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
266 |
107 |
$7K |
| 99218 |
|
42 |
13 |
$5K |
| 81025 |
|
547 |
439 |
$4K |
| 81001 |
|
1,539 |
1,245 |
$3K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
102 |
37 |
$3K |
| 97162 |
|
51 |
37 |
$3K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
430 |
174 |
$2K |
| 70450 |
Computed tomography, head or brain; without contrast material |
18 |
15 |
$2K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
59 |
54 |
$2K |
| 85730 |
|
378 |
306 |
$1K |
| 84484 |
|
154 |
65 |
$1K |
| 80061 |
Lipid panel |
97 |
89 |
$854.28 |
| 85610 |
|
338 |
265 |
$677.18 |
| 83690 |
|
134 |
95 |
$488.09 |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
12 |
12 |
$470.89 |
| 87430 |
|
58 |
55 |
$413.05 |
| 83735 |
|
69 |
64 |
$343.64 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
61 |
50 |
$249.38 |
| 81003 |
|
211 |
158 |
$241.73 |
| 87040 |
|
25 |
12 |
$239.44 |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
14 |
13 |
$232.19 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
30 |
26 |
$177.99 |
| 82077 |
|
12 |
12 |
$138.16 |
| 81000 |
|
30 |
29 |
$82.91 |
| 87081 |
|
15 |
15 |
$74.28 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
515 |
377 |
$0.00 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
25 |
24 |
$0.00 |
| J2175 |
Injection, meperidine hydrochloride, per 100 mg |
12 |
12 |
$0.00 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
140 |
102 |
$0.00 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
25 |
13 |
$0.00 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
18 |
15 |
$0.00 |